(Total Views: 100)
Posted On: 07/22/2025 4:06:01 PM
Post# of 29853
$PSTV
Due Diligence
Company: Plus Therapeutics Inc. (NASDAQ: PSTV)
Sector: Biotechnology (focus on cancer therapies)
Recent Catalysts:
Clinical trial results for a new cancer treatment
Strategic partnership with a major pharma company
Financial restructuring to improve cash flow
Technical Setup:
Recently crossed above 20-day moving average
Support: $0.32, $0.29
Resistance: $0.42, $0.50, $0.65
Short Interest & Float
Short Interest: 5.74 million shares
Short % of Float: 9.5%
Shares Outstanding: ~17 million
Float: ~14 million 2
Borrow Fee Rate: ~100%+ APR — very high, indicating strong short pressure and squeeze potential
Due Diligence
Company: Plus Therapeutics Inc. (NASDAQ: PSTV)
Sector: Biotechnology (focus on cancer therapies)
Recent Catalysts:
Clinical trial results for a new cancer treatment
Strategic partnership with a major pharma company
Financial restructuring to improve cash flow
Technical Setup:
Recently crossed above 20-day moving average
Support: $0.32, $0.29
Resistance: $0.42, $0.50, $0.65
Short Interest & Float
Short Interest: 5.74 million shares
Short % of Float: 9.5%
Shares Outstanding: ~17 million
Float: ~14 million 2
Borrow Fee Rate: ~100%+ APR — very high, indicating strong short pressure and squeeze potential
(0)
(0)
